Which has preferable earnings & valuation, DXCM or ALGN?

DexCom has higher revenue and earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DexCom $4.66B 6.01 $836.30M $2.34 31.02 Align Technology $4.03B 2.99 $410.35M $5.96 28.24

Is DXCM or ALGN more profitable?

DexCom has a net margin of 19.31% compared to Align Technology's net margin of 10.50%. DexCom's return on equity of 33.33% beat Align Technology's return on equity. Company Net Margins Return on Equity Return on Assets DexCom 19.31% 33.33% 13.19% Align Technology 10.50% 15.82% 10.17%

Does the media prefer DXCM or ALGN?

In the previous week, DexCom had 16 more articles in the media than Align Technology. MarketBeat recorded 21 mentions for DexCom and 5 mentions for Align Technology. DexCom's average media sentiment score of 1.49 beat Align Technology's score of 0.76 indicating that DexCom is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DexCom 17 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Align Technology 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer HQY or ALGN?

In the previous week, HealthEquity had 15 more articles in the media than Align Technology. MarketBeat recorded 20 mentions for HealthEquity and 5 mentions for Align Technology. Align Technology's average media sentiment score of 0.76 beat HealthEquity's score of 0.63 indicating that Align Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 6 Very Positive mention(s) 4 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Align Technology 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor HSIC or ALGN?

In the previous week, Henry Schein had 1 more articles in the media than Align Technology. MarketBeat recorded 6 mentions for Henry Schein and 5 mentions for Align Technology. Henry Schein's average media sentiment score of 0.78 beat Align Technology's score of 0.76 indicating that Henry Schein is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Henry Schein 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Align Technology 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is MEDP or ALGN more profitable?

Medpace has a net margin of 17.19% compared to Align Technology's net margin of 10.50%. Medpace's return on equity of 120.89% beat Align Technology's return on equity. Company Net Margins Return on Equity Return on Assets Medpace 17.19% 120.89% 24.79% Align Technology 10.50% 15.82% 10.17%

Does the media prefer MEDP or ALGN?

In the previous week, Medpace had 31 more articles in the media than Align Technology. MarketBeat recorded 36 mentions for Medpace and 5 mentions for Align Technology. Align Technology's average media sentiment score of 0.76 beat Medpace's score of 0.21 indicating that Align Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 7 Very Positive mention(s) 1 Positive mention(s) 27 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Align Technology 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, ALGN or QTRX?

Align Technology has higher revenue and earnings than Quanterix. Quanterix is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Align Technology $4.03B 2.99 $410.35M $5.96 28.24 Quanterix $138.90M 1.29 -$107.15M -$2.36 N/A

Does the media refer more to ALGN or QTRX?

In the previous week, Align Technology had 2 more articles in the media than Quanterix. MarketBeat recorded 5 mentions for Align Technology and 3 mentions for Quanterix. Align Technology's average media sentiment score of 0.76 beat Quanterix's score of 0.47 indicating that Align Technology is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Align Technology 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Quanterix 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Align Technology (ALGN) Competitors

$168.29 +6.58 (+4.07%)

Closing price 04:00 PM Eastern

Extended Trading

$168.00 -0.29 (-0.17%)

As of 06:54 PM Eastern

Compare

ALGN vs. DXCM, HQY, HSIC, MEDP, and QTRX

Should you buy Align Technology stock or one of its competitors? MarketBeat compares Align Technology with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Align Technology include DexCom (DXCM), HealthEquity (HQY), Henry Schein (HSIC), Medpace (MEDP), and Quanterix (QTRX). These companies are all part of the "medical" sector.

How does Align Technology compare to DexCom?

DexCom (NASDAQ:DXCM) and Align Technology (NASDAQ:ALGN) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings, media sentiment and institutional ownership.

DexCom has a beta of 1.45, suggesting that its share price is 45% more volatile than the broader market. Comparatively, Align Technology has a beta of 1.67, suggesting that its share price is 67% more volatile than the broader market.

DexCom has higher revenue and earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DexCom	$4.66B	6.01	$836.30M	$2.34	31.02
Align Technology	$4.03B	2.99	$410.35M	$5.96	28.24

97.8% of DexCom shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 0.3% of DexCom shares are held by company insiders. Comparatively, 0.8% of Align Technology shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, DexCom had 16 more articles in the media than Align Technology. MarketBeat recorded 21 mentions for DexCom and 5 mentions for Align Technology. DexCom's average media sentiment score of 1.49 beat Align Technology's score of 0.76 indicating that DexCom is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DexCom	17 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Align Technology	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

DexCom has a net margin of 19.31% compared to Align Technology's net margin of 10.50%. DexCom's return on equity of 33.33% beat Align Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DexCom	19.31%	33.33%	13.19%
Align Technology	10.50%	15.82%	10.17%

DexCom presently has a consensus target price of $82.42, indicating a potential upside of 13.54%. Align Technology has a consensus target price of $205.85, indicating a potential upside of 22.32%. Given Align Technology's higher probable upside, analysts plainly believe Align Technology is more favorable than DexCom.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DexCom	1 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	3 Strong Buy rating(s)	2.92
Align Technology	0 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.71

Summary

DexCom beats Align Technology on 13 of the 17 factors compared between the two stocks.

How does Align Technology compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Align Technology (NASDAQ:ALGN) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends, valuation and media sentiment.

HealthEquity has a beta of 0.21, suggesting that its stock price is 79% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.67, suggesting that its stock price is 67% more volatile than the broader market.

Align Technology has higher revenue and earnings than HealthEquity. Align Technology is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	5.47	$215.20M	$2.67	32.21
Align Technology	$4.03B	2.99	$410.35M	$5.96	28.24

In the previous week, HealthEquity had 15 more articles in the media than Align Technology. MarketBeat recorded 20 mentions for HealthEquity and 5 mentions for Align Technology. Align Technology's average media sentiment score of 0.76 beat HealthEquity's score of 0.63 indicating that Align Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	6 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Align Technology	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

HealthEquity has a net margin of 17.25% compared to Align Technology's net margin of 10.50%. Align Technology's return on equity of 15.82% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.25%	14.75%	9.22%
Align Technology	10.50%	15.82%	10.17%

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 1.6% of HealthEquity shares are owned by company insiders. Comparatively, 0.8% of Align Technology shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

HealthEquity presently has a consensus target price of $110.57, suggesting a potential upside of 28.57%. Align Technology has a consensus target price of $205.85, suggesting a potential upside of 22.32%. Given HealthEquity's stronger consensus rating and higher probable upside, equities analysts plainly believe HealthEquity is more favorable than Align Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.86
Align Technology	0 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.71

Summary

HealthEquity beats Align Technology on 9 of the 16 factors compared between the two stocks.

How does Align Technology compare to Henry Schein?

Henry Schein (NASDAQ:HSIC) and Align Technology (NASDAQ:ALGN) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, media sentiment, earnings, profitability, analyst recommendations, valuation and risk.

In the previous week, Henry Schein had 1 more articles in the media than Align Technology. MarketBeat recorded 6 mentions for Henry Schein and 5 mentions for Align Technology. Henry Schein's average media sentiment score of 0.78 beat Align Technology's score of 0.76 indicating that Henry Schein is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	6 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Align Technology	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 0.9% of Henry Schein shares are owned by insiders. Comparatively, 0.8% of Align Technology shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Henry Schein currently has a consensus price target of $86.83, suggesting a potential upside of 13.81%. Align Technology has a consensus price target of $205.85, suggesting a potential upside of 22.32%. Given Align Technology's stronger consensus rating and higher possible upside, analysts clearly believe Align Technology is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.36
Align Technology	0 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.71

Align Technology has lower revenue, but higher earnings than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18B	0.66	$398M	$3.31	23.05
Align Technology	$4.03B	2.99	$410.35M	$5.96	28.24

Align Technology has a net margin of 10.50% compared to Henry Schein's net margin of 2.95%. Align Technology's return on equity of 15.82% beat Henry Schein's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.95%	15.44%	5.53%
Align Technology	10.50%	15.82%	10.17%

Henry Schein has a beta of 0.82, suggesting that its stock price is 18% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.67, suggesting that its stock price is 67% more volatile than the broader market.

Summary

Align Technology beats Henry Schein on 12 of the 17 factors compared between the two stocks.

How does Align Technology compare to Medpace?

Medpace (NASDAQ:MEDP) and Align Technology (NASDAQ:ALGN) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, media sentiment, risk, profitability, valuation and earnings.

Medpace presently has a consensus target price of $467.08, suggesting a potential upside of 1.83%. Align Technology has a consensus target price of $205.85, suggesting a potential upside of 22.32%. Given Align Technology's stronger consensus rating and higher possible upside, analysts clearly believe Align Technology is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medpace	1 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.20
Align Technology	0 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.71

78.0% of Medpace shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 20.5% of Medpace shares are owned by company insiders. Comparatively, 0.8% of Align Technology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Medpace had 31 more articles in the media than Align Technology. MarketBeat recorded 36 mentions for Medpace and 5 mentions for Align Technology. Align Technology's average media sentiment score of 0.76 beat Medpace's score of 0.21 indicating that Align Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medpace	7 Very Positive mention(s)	1 Positive mention(s)	27 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Align Technology	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Medpace has a net margin of 17.19% compared to Align Technology's net margin of 10.50%. Medpace's return on equity of 120.89% beat Align Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medpace	17.19%	120.89%	24.79%
Align Technology	10.50%	15.82%	10.17%

Medpace has a beta of 1.18, meaning that its stock price is 18% more volatile than the broader market. Comparatively, Align Technology has a beta of 1.67, meaning that its stock price is 67% more volatile than the broader market.

Medpace has higher earnings, but lower revenue than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medpace	$2.53B	5.18	$451.12M	$15.91	28.83
Align Technology	$4.03B	2.99	$410.35M	$5.96	28.24

Summary

Medpace beats Align Technology on 9 of the 17 factors compared between the two stocks.

How does Align Technology compare to Quanterix?

Align Technology (NASDAQ:ALGN) and Quanterix (NASDAQ:QTRX) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, earnings and risk.

Align Technology has a net margin of 10.50% compared to Quanterix's net margin of -71.86%. Align Technology's return on equity of 15.82% beat Quanterix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Align Technology	10.50%	15.82%	10.17%
Quanterix	-71.86%	-23.92%	-17.66%

Align Technology presently has a consensus target price of $205.85, suggesting a potential upside of 22.32%. Quanterix has a consensus target price of $4.00, suggesting a potential upside of 5.26%. Given Align Technology's stronger consensus rating and higher probable upside, equities analysts plainly believe Align Technology is more favorable than Quanterix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Align Technology	0 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.71
Quanterix	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

88.4% of Align Technology shares are owned by institutional investors. Comparatively, 86.5% of Quanterix shares are owned by institutional investors. 0.8% of Align Technology shares are owned by company insiders. Comparatively, 1.5% of Quanterix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Align Technology has a beta of 1.67, suggesting that its share price is 67% more volatile than the broader market. Comparatively, Quanterix has a beta of 1.14, suggesting that its share price is 14% more volatile than the broader market.

Align Technology has higher revenue and earnings than Quanterix. Quanterix is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Align Technology	$4.03B	2.99	$410.35M	$5.96	28.24
Quanterix	$138.90M	1.29	-$107.15M	-$2.36	N/A

In the previous week, Align Technology had 2 more articles in the media than Quanterix. MarketBeat recorded 5 mentions for Align Technology and 3 mentions for Quanterix. Align Technology's average media sentiment score of 0.76 beat Quanterix's score of 0.47 indicating that Align Technology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Align Technology	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Quanterix	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Align Technology beats Quanterix on 16 of the 17 factors compared between the two stocks.

Get Align Technology News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ALGN vs. The Competition

Export

Metric	Align Technology	MED/DENTAL Industry	Medical Sector	NASDAQ Exchange
Market Cap	$12.05B	$15.44B	$6.44B	$12.46B
Dividend Yield	N/A	1.22%	2.69%	5.22%
P/E Ratio	28.24	17.70	23.87	24.36
Price / Sales	2.99	2.26	521.52	117.06
Price / Cash	14.04	13.27	41.27	57.13
Price / Book	2.98	3.29	9.99	6.73
Net Income	$410.35M	$534.24M	$3.56B	$337.03M
7 Day Performance	-2.86%	1.39%	-0.89%	0.09%
1 Month Performance	N/A	N/A	N/A	-1.78%
1 Year Performance	-6.50%	1.34%	28.76%	33.98%

Align Technology Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ALGN Align Technology	3.3033 of 5 stars	$168.29 +4.1%	$205.85 +22.3%	-9.8%	$12.05B	$4.03B	28.24	20,290	Analyst Upgrade
DXCM DexCom	4.5482 of 5 stars	$74.87 +1.5%	$82.42 +10.1%	-16.2%	$28.45B	$4.66B	32.00	11,000	Positive News Analyst Forecast
HQY HealthEquity	4.4389 of 5 stars	$90.64 +3.0%	$111.53 +23.1%	-17.9%	$7.36B	$1.31B	33.95	2,814	News Coverage Earnings Report Analyst Forecast Insider Trade
HSIC Henry Schein	3.4689 of 5 stars	$76.40 -0.2%	$86.83 +13.7%	+7.3%	$8.72B	$13.18B	23.08	25,000
MEDP Medpace	2.1584 of 5 stars	$451.47 +1.0%	$467.08 +3.5%	+47.3%	$12.77B	$2.53B	28.38	6,200	Trending News Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ALGN) was last updated on 6/4/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Align Technology (ALGN) Competitors

ALGN vs. DXCM, HQY, HSIC, MEDP, and QTRX

How does Align Technology compare to DexCom?

Summary

How does Align Technology compare to HealthEquity?

Summary

How does Align Technology compare to Henry Schein?

Summary

How does Align Technology compare to Medpace?

Summary

How does Align Technology compare to Quanterix?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALGN vs. The Competition

Align Technology Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Align Technology (ALGN) Competitors

ALGN vs. DXCM, HQY, HSIC, MEDP, and QTRX

How does Align Technology compare to DexCom?

Which has more volatility and risk, DXCM or ALGN?

Which has preferable earnings & valuation, DXCM or ALGN?

Do insiders and institutionals believe in DXCM or ALGN?

Does the media prefer DXCM or ALGN?

Is DXCM or ALGN more profitable?

Do analysts rate DXCM or ALGN?

Summary

How does Align Technology compare to HealthEquity?

Which has more volatility & risk, HQY or ALGN?

Which has stronger earnings & valuation, HQY or ALGN?

Does the media prefer HQY or ALGN?

Is HQY or ALGN more profitable?

Do insiders & institutionals hold more shares of HQY or ALGN?

Do analysts rate HQY or ALGN?

Summary

How does Align Technology compare to Henry Schein?

Does the media favor HSIC or ALGN?

Do insiders and institutionals hold more shares of HSIC or ALGN?

Do analysts rate HSIC or ALGN?

Which has better valuation & earnings, HSIC or ALGN?

Is HSIC or ALGN more profitable?

Which has more risk and volatility, HSIC or ALGN?

Summary

How does Align Technology compare to Medpace?

Do analysts prefer MEDP or ALGN?

Do institutionals & insiders have more ownership in MEDP or ALGN?

Does the media prefer MEDP or ALGN?

Is MEDP or ALGN more profitable?

Which has more risk and volatility, MEDP or ALGN?

Which has higher earnings & valuation, MEDP or ALGN?

Summary

How does Align Technology compare to Quanterix?

Is ALGN or QTRX more profitable?

Do analysts prefer ALGN or QTRX?

Do institutionals and insiders have more ownership in ALGN or QTRX?

Which has more risk & volatility, ALGN or QTRX?

Which has better earnings & valuation, ALGN or QTRX?

Does the media refer more to ALGN or QTRX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALGN vs. The Competition

Align Technology Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools